We are proud to announce our team's breakthrough research achievements in plasma-based disinfection and sanitation efforts, culminating in a Phase 1 SBIR award from NASA.

AAPlasma, in their support of Zephyro's efforts to control and convert CO2 emissions, teamed up with the fine folks at the Radical Development Center.

Our research manuscript was chosen for the cover of the Dermatology and Venereology Review journal.

The manuscript is on “The use of non-thermal atmospheric plasma for the treatment of in situ cutaneous squamous cell carcinoma: a case series.”

Greg Fridman, CEO and Charles Bailey, COO attended the 2023 Defense Manufacturing Conference (DMC) in Nashville, TN.

November 15, 2023, Philadelphia, PA

In order to expand our manufacturing capabilities, we are opening a second location for AAPlasma, located at 700 W Park Ave, Perkasie, PA 18944. This is a strategic co-location with our manufacturing partner, EFE Laboratories.

The AAPlasma team was awarded the PHL Made Grant to expand and grow our manufacturing capabilities. We are proudly labeling all of our plasma systems with "Made with 💜 in Philly" and will continue our efforts to manufacture everything in the USA 🇺🇸.